Drug Information Association, Online
May 12 2006
This session will examine new and innovative methods, standards and technologies that are being applied to the field of clinical research resulting in improved standardization, efficiency and cost effectiveness. Specifically, this session will review CDISC and HL7 standards, new technologies that enhance safety oversight and important issues to consider in the area of clinical study protocols. Additionally this session will review a new technological approach to the collection and assessment of clinical data for CNS studies as well as discuss new advancements in the benchmarking of clinical study costs.
|
|
Invited Speakers:
|
|
1)REBECCA KUSH President-CDISC2)ROBERT P.. VAN MANEN,, MSC Worldwide Technical Director, Phase Forward Inc. 3)HELLE GAWRYLEWSKII Director, Medical Writing, Medical Knowledge Management Johnson and Johnson, PRD
|
|